Neoplasma Vol.66, No.4, p.603-608, 2019
|
Title: Aberrant methylation of miR-125b1 in gastric cancer: A case-control study |
Author: M. Raad, Z. Salehi, S. T. Sasani, F. Mashayekhi, K. Aminian, M. H. Koutenayi |
|
Abstract: Gastric cancer (GC) is a complex heterogeneous process and the molecular mechanisms underlying its initiation or propagation are still not very well characterized. Aberrant gene expressions are key features of cancer. DNA methylation in a promoter region is an important epigenetic mechanism for the gene silencing. Here, the impact of DNA methylation in regulating the expression of miR-125b1 is explored. A total of 285 genetically unrelated subjects including 175 healthy controls and a total of 110 GC patients participated in this study. We performed nested methylation-specific polymerase chain reaction (MS-PCR) to evaluate methylation pattern of miR-125b1 promoter and quantitative real-time polymerase chain reaction (qRT-PCR) to determine the RNA expression changes in GC and normal tissues. The frequency of methylated allele was 24.5% in GC cases but only 10% in normal tissues. Statistically significant correlation between CpG dinucleotide methylation of miR-125b1 promoter and increased risk of gastric adenocarcinoma was observed (OR=2.57; 95%CI 1.60–4.13; p=0.0001). In addition, miR-125b1 promoter methylation correlated with tumor location and stages. Expression of miR-125b1 was much higher in normal tissue compared to cancerous tissue. However, methylation status of the miR-125b1 promoter was not correlated with miR-125b1 expression in cancerous specimens (p
|
|
Keywords: gastric cancer, promoter methylation, miR-125b1, epigenetics, gene expression |
|
Published online: 29-Jul-2019
|
Year: 2019, Volume: 66, Issue: 4 |
Page From: 603, Page To: 608 |
doi:10.4149/neo_2018_180925N716
|
|
download file |
|
|
|
|